1.Initiation of Punitive Compensation System in Drug Field in China
Han TANG ; Yue YANG ; Changli LINGHU ; Zhi ZENG
China Pharmacy 2007;0(25):-
OBJECTIVE:To initiate punitive compensation system in drug field to make up the insufficiency in the legislation of legal liability of drug injury events,regulate unlawful act of pharmaceutical enterprises and enhance supervision efficiency in drug field. METHODS: The definition and function,etc. of the punitive compensation system were studied by reviewing the pertinent legal clauses both at home and abroad,furthermore,the necessity of initiating the punitive compensation system in China was analyzed and the application conditions of the punitive compensation system was put forward. RESULTS & CONCLUSIONS: It is urgent to initiate the punitive compensation system in drug field and establish a punitive system with Chinese characteristics. It is advisable to initiate the related contents in Pharmaceutical Administration Law of the People’s Republic of China and define the application conditions of the punitive compensation system as well as the way to establish the amount of compensation,etc.
4.Comparative study of dissolved matter of glycyrrhizic acid before and after supermicro-pulverization of Radix Glycyrrhizae.
Zhi-meng LI ; Yue-sheng WANG ; Xiao-ming LI ; Han YAN ; Jun ZHANG ; Xiao-jun TANG ; Xin LI
China Journal of Chinese Materia Medica 2003;28(11):1030-1033
OBJECTIVETo investigate various activities of dissolved matter of glycyrrhizic acid of Radix Glycyrrhizae and the powder by supermicro-pulverization.
METHODThe contents of glycyrrhizic acid in different samples were tested.
RESULTThe dissolved matter of glycyrrhizic acid was greatly increased by supermicro-pulverization. The more time used for grinding, the smaller the size of the powder, and the easier the glycyrrhizic acid would be dissolved.
CONCLUSIONSupermicro-pulverization is helpful to the dissolved matter of glycyrrhizic acid of Radix Glycyrrhizae, and the size of powder exerts great influence on dissolved matter of glycyrrhizic acid.
Drug Combinations ; Drugs, Chinese Herbal ; chemistry ; Glycyrrhiza ; chemistry ; Glycyrrhizic Acid ; analysis ; Particle Size ; Plant Roots ; chemistry ; Plants, Medicinal ; chemistry ; Powders ; Solubility
5.Logistic regression analysis of the risk factors in progressive hemorrhagic injury after severe head injury
Guang FENG ; Ji-Xin DUAN ; Zhi-Jun ZHONG ; Han-Chang YU ; Ling HAN ; Hui TANG
Chinese Journal of Neuromedicine 2010;09(11):1150-1153
Objective To study the risk factors related with progressive hemorrhagic injury (PHI)after severe head injury for a view to early diagnosis and treatment for this disease and providing a basis for effective prevention. Methods In a retrospective study of 262 patients with severe brain injury in considering the clinical data of the PHI, the occurrence is variable, and age, gender, bleeding site, type of bleeding, dilated pupils starus, level of systolic blood pressure on admission, time of CT for the first time,GOS scores, injured mechanism, interval between first and second time CT, application of high-dose mannitol, platelet (PLT) count, prothrombin time (PT), activated partial prothrombin time (APTT) were considered as independent variables. Results The incidence rate of having PHI was 47.7% (125/262);single-factor analysis revealed that, as compared with those in patients with non-PHI, 7 factors in patients with PHI were significantly different, namely, age, type of hemorrhage, interval between injury and first-time CT, GCS scores, PLT count, PT and APTT. Multivariate logistic regression analysis of the results showed that interval between injury and first-time CT, GCS scores, PLT count were the risk factors of having PHI, and their OR values were 3.5448, 3.2975 and 2.2361, respectively. Conclusion For patients with severe brain injury, the sooner the first time CT examination is performed, the lower the GCS scores are and the lower the PLT count is, the higher risk of having PHI is. Thus, dynamic CT formal review is suggested to improve the early diagnosis and treatment of PHI.
6.Anti-tumor activity and mechanism of T03 in vitro and in vivo.
Ke TANG ; Han-Ze YANG ; Yan LI ; Kang TIAN ; Chao LI ; Wan-Qi ZHOU ; Fei NIU ; Zhi-Qiang FENG ; Xiao-Guang CHEN
Acta Pharmaceutica Sinica 2014;49(6):861-868
The purpose of this study is to investigate the activity and mechanism of a new anti-tumor agent T03. MTT and colony formation assay were performed to determine anti-proliferation activity of T03 in vitro. Antitumor activity was observed by Renca xenograft model in vivo. The effect of T03 on cell cycle and apoptosis were measured by FCM analysis. Western blotting was performed to investigate the expression level of proteins in HepG2 cell lines treated with T03. T03 had anti-tumor activity by inhibiting tumor cell growth and colony formation in vitro, especially on hepatocellular carcinoma cells (HCC). At the concentration of 10 micromol x L(-1), T03 induced cell apoptosis and cell cycle arrest in HCC. Moreover, it proved that T03 reduced the tumor weight with the rate of 42.30% without any obviously side effect in Renca xenograft model. At the concentration of 2.0 micromol x L(-1), T03 was able to reduce the level of p-c-Raf (Ser259), and thus blocked Raf/MEK/ERK and AKT signaling in HepG2 cell lines. The result suggested that T03 has the potential to inhibit cell proliferation and induce cell apoptosis both in vitro and in vivo, particularly active against HCC, indicating T03 and its analogues may serve as a new anti-cancer drug against hepatocellular carcinoma.
Animals
;
Antineoplastic Agents
;
pharmacology
;
Apoptosis
;
drug effects
;
Carcinoma, Hepatocellular
;
pathology
;
Cell Cycle Checkpoints
;
drug effects
;
Cell Proliferation
;
drug effects
;
Hep G2 Cells
;
drug effects
;
Humans
;
Liver Neoplasms
;
pathology
;
Signal Transduction
;
drug effects
;
Xenograft Model Antitumor Assays
7.Cell penetrating peptides enhance intracellular translocation and function of siRNA encapsulated in Pegylated liposomes.
Wei WANG ; Ning TANG ; Chun-ling ZHANG ; Xing-jun LIU ; Han HU ; Zhi-xiang ZHANG ; Wei LIANG
Acta Pharmaceutica Sinica 2006;41(2):142-148
AIMTo prepare the PEGylated liposomes modified with cell penetrating peptides, which protect siRNA from nuclease degradation and deliver efficiently siRNA into cells to facilitate silencing of target gene.
METHODSThe purity of R8-PEG-PE and pNP-PEG-PE was detected by HPLC; the quantity of R8, PEG-DPPE modified R8, and R8 attached to the out membrane surface of the liposomal siRNA by transfer from R8-PEG-DPPE micelles to the liposomes was tested by fluorescence; Size and size distribution of siRNA loaded liposomes with and without attached R8 were determined by Zetasizer 5000; A comparison of mediated siRNA transfection efficiency between R8-liposomes and lipofectamine 2000 was examined by individual inside cell fluorescence intensity; The growth inhibition of small cell lung carcinoma NCI-H446 cells treated with R8-liposomal hdm2-siRNA or lipofectamine 2000-hdm2-siRNA complex was tested by MTT assay.
RESULTSThe retention times of PEG-DPPE and R8-PEG-DPPE were 9.0 min and 7.8 min, respectively. Fluorescence scanning indicated that lipids composed of liposomes and siRNAs didn't interfere to the determination of R8 when it was attached to the liposomal siRNA. The cells treated with R8-liposomal hdm2-siRNA significantly enhanced the cellular uptake of hdm2-siRNA and facilitated the functions of hdm2-siRNA through silencing of target gene which, in turn, inhibited tumor cell growth, compared with lipofectamine 2000.
CONCLUSIONThe R8 attached liposomes are shown to be powerful carriers for delivery siRNAs into cell to silence targeted gene.
Carcinoma, Small Cell ; metabolism ; pathology ; Cell Line, Tumor ; Cell Proliferation ; drug effects ; Gene Silencing ; Gene Targeting ; Humans ; Liposomes ; Lung Neoplasms ; metabolism ; pathology ; Oligopeptides ; administration & dosage ; pharmacology ; Phosphatidylethanolamines ; Polyethylene Glycols ; Proto-Oncogene Proteins c-mdm2 ; genetics ; metabolism ; RNA, Small Interfering ; administration & dosage ; metabolism ; pharmacology ; Transduction, Genetic
8.Effect of silver nanoparticle dressing on second degree burn wound.
Jiong CHEN ; Chun-mao HAN ; Xiao-wei LIN ; Zhi-jian TANG ; Shi-jie SU
Chinese Journal of Surgery 2006;44(1):50-52
OBJECTIVETo explore the influence of silver nanoparticle dressing on prevention of infection and healing of the second degree burn wound.
METHODSOne hundred and ninety-one burn patients with second degree including superficial and deep burn wound were randomly divided into three groups. Group A including 65 cases was treated by silver nanoparticle dressing on wounds, and group B (63 cases) and group C (63 cases) were treated by 1% silver sulfadiazine cream and vaseline gauze on their wounds, respectively. Dressing was changed daily, and wound swab bacterial cultures were performed before and after dressing change, and also wound healing times were recorded in each patient.
RESULTSGroup A and B were similar in their bacterium colonizations on wound after treatment with the silver nanoparticle dressing and 1% silver sulfadiazine cream, and they had a similar effect on reducing bacterium colonization on wound after treatment, while in vaseline gauze group bacterium colonization on wound increased after treatment. In group A the wound healing time of superficial second degree was significantly shorter than those in group B and group C (P < 0.01). In deep second degree wounds the healing time in group A was much shorter than that in group C (P < 0.01), but had no significant difference when compared with group B (P > 0.05).
CONCLUSIONSilver nanoparticle dressing can be used on second degree burn wound and can decrease the risk of wound infection and accelerate wound healing.
Adult ; Anti-Infective Agents, Local ; therapeutic use ; Bandages ; Burns ; therapy ; Female ; Humans ; Male ; Particle Size ; Petrolatum ; therapeutic use ; Silver ; therapeutic use ; Silver Sulfadiazine ; therapeutic use ; Surgical Sponges ; Wound Healing ; drug effects ; Wound Infection ; prevention & control
10.Detection of hepatitis B virus cccDNA in liver tissues of patients with hepatocellular carcinoma.
Tao ZHANG ; Tao HAN ; Ying-tang GAO ; Hao CHEN ; Zhi DU ; Yi-jun WANG
Chinese Journal of Hepatology 2007;15(3):232-233
Adult
;
Aged
;
Carcinoma, Hepatocellular
;
blood
;
pathology
;
virology
;
DNA, Viral
;
blood
;
Female
;
Hepatitis B
;
blood
;
virology
;
Hepatitis B virus
;
genetics
;
Humans
;
Liver
;
pathology
;
virology
;
Liver Neoplasms
;
virology
;
Male
;
Middle Aged